Attached files

file filename
EX-99.7 - EXHIBIT 99.7 - Xtant Medical Holdings, Inc.tv491258_ex99-7.htm
EX-99.6 - EXHIBIT 99.6 - Xtant Medical Holdings, Inc.tv491258_ex99-6.htm
EX-99.5 - EXHIBIT 99.5 - Xtant Medical Holdings, Inc.tv491258_ex99-5.htm
EX-99.4 - EXHIBIT 99.4 - Xtant Medical Holdings, Inc.tv491258_ex99-4.htm
EX-99.3 - EXHIBIT 99.3 - Xtant Medical Holdings, Inc.tv491258_ex99-3.htm
EX-99.2 - EXHIBIT 99.2 - Xtant Medical Holdings, Inc.tv491258_ex99-2.htm
EX-99.1 - EXHIBIT 99.1 - Xtant Medical Holdings, Inc.tv491258_ex99-1.htm
EX-8.1 - EXHIBIT 8.1 - Xtant Medical Holdings, Inc.tv491258_ex8-1.htm
EX-5.1 - EXHIBIT 5.1 - Xtant Medical Holdings, Inc.tv491258_ex5-1.htm
EX-4.17 - EXHIBIT 4.17 - Xtant Medical Holdings, Inc.tv491258_ex4-17.htm
S-1/A - S-1/A - Xtant Medical Holdings, Inc.tv491258_s1a.htm

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the reference to our firm under the caption “Experts” in the Registration Statement (Form S-1/A) for the registration of 1,137,515 shares of common stock and the incorporation by reference therein of our report dated April 2, 2018, with respect to the consolidated financial statements of Xtant Medical Holdings, Inc. included in its Annual Report on Form 10-K for the year ended December 31, 2017, filed with the Securities and Exchange Commission.

 

  /s/ EKS&H LLLP
   
April 17, 2018  
Denver, Colorado